Overview

Noradrenergic Activity, Cognition and Major Depressive Disorder

Status:
Completed
Trial end date:
2018-10-01
Target enrollment:
Participant gender:
Summary
This study investigates influences of nordadrenergic activity on cognition in patients with major depression regarding influences of early life stress.
Phase:
N/A
Details
Lead Sponsor:
Charite University, Berlin, Germany
Treatments:
Yohimbine